Martin Štefanič - Concepedia

Concepedia

Author

Martin Štefanič

Universität Ulm

Also Known As

M Stefanic, M. F. Stefanic, M. Stefanic, M. Štefanič, Martin Stefanic, Martin Stefanič, Martin Štefanič

54

Publications

1.6K

Citations

21

H-Index

61

Concepts

All Affiliations

Universität Ulm Boehringer Ingelheim (Germany)Jožef Stefan Institute University Hospital Ulm Boehringer Ingelheim (Austria)

MŠ

About

Martin Štefanič is an author at Universität Ulm specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	14	557
2	Biomedical Engineering	6	6	195
3	Engineering	5	5	182
4	Health Sciences	4	4	196
5	Public Health	1	1	59

Martin Štefanič

×

31

Publications

1.6K

Citations

21

H-Index

	Year	Citations
Rhenium 188–labeled anti-CD66 (a, b, c, e) monoclonal antibody to intensify the conditioning regimen prior to stem cell transplantation for patients with high-risk acute myeloid leukemia or myelodysplastic syndrome: results of a phase I-II study Donald Bunjes, Inga Buchmann, Christian Duncker, Blood	2001	168
Phase I Study of the Angiogenesis Inhibitor BIBF 1120 in Patients with Advanced Solid Tumors K. Mross, Martin Štefanič, Daniela Gmehling, Clinical Cancer Research	2009	164
Cardiac toxicity of bone marrow transplantation: predictive value of cardiologic evaluation before transplant. Bernd Hertenstein, Martin Štefanič, T Schmeiser, Journal of Clinical Oncology	1994	154
Tumor necrosis factor induces proliferation of neoplastic B cells from chronic lymphocytic leukemia W. Digel, Martin Štefanič, W Schöniger, Blood	1989	149
A phase II double-blind study to investigate efficacy and safety of two doses of the triple angiokinase inhibitor BIBF 1120 in patients with relapsed advanced non-small-cell lung cancer Martin Reck, R. Kaiser, C. Eschbach, Annals of Oncology MedicineClinical TrialsBronchial NeoplasmPharmacotherapyCancer Treatment	2011	149
Low incidence of invasive fungal infections after bone marrow transplantation in patients receiving amphotericin B inhalations during neutropenia Bernd Hertenstein, Winfried V. Kern, T. Schmeiser, Annals of Hematology TransplantationBone Marrow FailureHematologyInvasive Fungal InfectionsClinical Mycology	1994	87
Interferon-α And Donor Buffy Coat Transfusions For Treatment Of Relapsed Chronic Myeloid Leukemia After Allogeneic Bone Marrow Transplantation Bernd Hertenstein, Markus Wiesneth, J. Novotný, Transplantation Mixed-phenotype Acute LeukemiaImmunologyPathologyImmunotherapyMyeloid Neoplasia	1993	83
Apatite nanoparticles strongly improve red blood cell cryopreservation by mediating trehalose delivery via enhanced membrane permeation Martin Štefanič, Kevin Ward, Harvey Tawfik, Biomaterials NanoparticlesTissue EngineeringEngineeringTherapeutic NanomaterialsNano-drug Delivery	2017	69
Non-infectious lung complications are closely associated with chronic graft-versus-host disease: a single center study of incidence, risk factors and outcome Christian Duncker, Dagmar Dohr, Stephanie von Harsdorf, Bone Marrow Transplantation Graft-versus-host DiseaseTransplantationNon-infectious Lung ComplicationsMedicineClinical Epidemiology	2000	59
Rapid biomimetic deposition of octacalcium phosphate coatings on zirconia ceramics (Y-TZP) for dental implant applications Martin Štefanič, Kristoffer Krnel, Irena Pribošič, Applied Surface Science Materials ScienceZirconia CeramicsEngineeringCorrosionRapid Biomimetic Deposition	2012	52

Page 1